These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34050634)

  • 1. Effects of Protein Source on Liposome Uptake by Cells: Corona Composition and Impact of the Excess Free Proteins.
    Yang K; Reker-Smit C; Stuart MCA; Salvati A
    Adv Healthc Mater; 2021 Jul; 10(14):e2100370. PubMed ID: 34050634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuning liposome composition to modulate corona formation in human serum and cellular uptake.
    Yang K; Mesquita B; Horvatovich P; Salvati A
    Acta Biomater; 2020 Apr; 106():314-327. PubMed ID: 32081780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spotlight on the protein corona of liposomes.
    Onishchenko N; Tretiakova D; Vodovozova E
    Acta Biomater; 2021 Oct; 134():57-78. PubMed ID: 34364016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles.
    Francia V; Yang K; Deville S; Reker-Smit C; Nelissen I; Salvati A
    ACS Nano; 2019 Oct; 13(10):11107-11121. PubMed ID: 31525954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential cellular responses to FDA-approved nanomedicines: an exploration of albumin-based nanocarriers and liposomes in protein corona formation.
    Putri AD; Hsu MJ; Han CL; Chao FC; Hsu CH; Lorenz CD; Hsieh CM
    Nanoscale; 2023 Nov; 15(44):17825-17838. PubMed ID: 37850423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ analysis of liposome hard and soft protein corona structure and composition in a single label-free workflow.
    Kari OK; Ndika J; Parkkila P; Louna A; Lajunen T; Puustinen A; Viitala T; Alenius H; Urtti A
    Nanoscale; 2020 Jan; 12(3):1728-1741. PubMed ID: 31894806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome protein corona characterization as a new approach in nanomedicine.
    Capriotti AL; Cavaliere C; Piovesana S
    Anal Bioanal Chem; 2019 Jul; 411(19):4313-4326. PubMed ID: 30758528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers.
    Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Hartman KA; Sherman MB; De Rosa E; Kirui DK; Salvatore F; Tasciotti E
    ACS Nano; 2017 Mar; 11(3):3262-3273. PubMed ID: 28264157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of extracellular vesicles into immune cells is enhanced by the protein corona.
    Dietz L; Oberländer J; Mateos-Maroto A; Schunke J; Fichter M; Krämer-Albers EM; Landfester K; Mailänder V
    J Extracell Vesicles; 2023 Dec; 12(12):e12399. PubMed ID: 38124271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the protein corona on liposome-liposome and liposome-cell interactions.
    Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Sherman MB; Parodi A; Salvatore F; Tasciotti E
    Int J Nanomedicine; 2016; 11():3049-63. PubMed ID: 27445473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionalization of Liposomes with Hydrophilic Polymers Results in Macrophage Uptake Independent of the Protein Corona.
    Weber C; Voigt M; Simon J; Danner AK; Frey H; Mailänder V; Helm M; Morsbach S; Landfester K
    Biomacromolecules; 2019 Aug; 20(8):2989-2999. PubMed ID: 31268685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlating Corona Composition and Cell Uptake to Identify Proteins Affecting Nanoparticle Entry into Endothelial Cells.
    Aliyandi A; Reker-Smit C; Bron R; Zuhorn IS; Salvati A
    ACS Biomater Sci Eng; 2021 Dec; 7(12):5573-5584. PubMed ID: 34761907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biomolecular corona of nanoparticles in circulating biological media.
    Pozzi D; Caracciolo G; Digiacomo L; Colapicchioni V; Palchetti S; Capriotti AL; Cavaliere C; Zenezini Chiozzi R; Puglisi A; Laganà A
    Nanoscale; 2015 Sep; 7(33):13958-66. PubMed ID: 26222625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum.
    Mirshafiee V; Kim R; Mahmoudi M; Kraft ML
    Int J Biochem Cell Biol; 2016 Jun; 75():188-95. PubMed ID: 26643610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
    Cai R; Chen C
    Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How protein coronas determine the fate of engineered nanoparticles in biological environment.
    Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
    Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface chemistry and serum type both determine the nanoparticle-protein corona.
    Pozzi D; Caracciolo G; Capriotti AL; Cavaliere C; La Barbera G; Anchordoquy TJ; Laganà A
    J Proteomics; 2015 Apr; 119():209-17. PubMed ID: 25731725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
    Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K
    ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of surface chemistry and morphology of nanoparticles on protein corona formation.
    Bilardo R; Traldi F; Vdovchenko A; Resmini M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1788. PubMed ID: 35257495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.